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Escherichia coli O157:H7 and other pathogenic E. coli strains are enteric pathogens asso-
ciated with food safety threats and which remain a significant cause of morbidity and
mortality worldwide. In the current study, we investigated whether enterohemorrhagic E.
coli (EHEC), Shiga toxin-producing E. coli (STEC), and enteropathogenic E. coli (EPEC)
strains can be rapidly and specifically differentiated with multiplex PCR (mPCR) utilizing
selected biomarkers associated with each strain’s respective virulence genotype. Primers
were designed to amplify multiple intimin (eae) and long polar fimbriae (lpfA) variants, the
bundle-forming pilus gene bfpA, and the Shiga toxin-encoding genes stx1 and stx2. We
demonstrated consistent amplification of genes specific to the prototype EHEC O157:H7
EDL933 (lpfA1-3, lpfA2-2, stx1, stx2, and eae-γ) and EPECO127:H6 E2348/69 (eae-α, lpfA1-
1, and bfpA) strains using the optimizedmPCRprotocolwith purified genomicDNA (gDNA).
A screen of gDNA from isolates in a diarrheagenic E. coli collection revealed that the
mPCR assay was successful in predicting the correct pathotype of EPEC and EHEC clones
grouped in the distinctive phylogenetic disease clusters EPEC1 and EHEC1, andwas able to
differentiate EHEC1 from EHEC2 clusters.The assay detection threshold was 2× 104 CFU
per PCR reaction for EHEC and EPEC. mPCR was also used to screen Argentinean clinical
samples from hemolytic uremic syndrome and diarrheal patients, resulting in 91% sensi-
tivity and 84% specificity when compared to establishedmolecular diagnostic procedures.
In conclusion, our mPCR methodology permitted differentiation of EPEC, STEC and EHEC
strains from other pathogenic E. coli ; therefore, the assay becomes an additional tool for
rapid diagnosis of these organisms.
Keywords: Shiga toxin-producing E. coli, enterohemorrhagic E. coli, enteropathogenic E. coli, E. coli O157,
diagnostics
INTRODUCTION
Rapid diagnosis of pathogenic E. coli strains is an increasingly
important issue to address in public health. Infections with Shiga
toxin-producing E. coli (STEC) and among those enterohemor-
rhagic E. coli (EHEC), can result in abdominal cramping and
diarrhea (with or without blood). A small percentage of patients
can progress to a more severe and often fatal condition called
hemolytic uremic syndrome (HUS). STEC/EHEC strains are
found in industrialized nations as well as developing countries and
typical cases in theU.S. are associatedwith food-borne contamina-
tion. EnteropathogenicE. coli (EPEC) is frequently associatedwith
outbreaks of infantile diarrhea indevelopingnations (Orskov et al.,
1990), and is a contributor to diarrheagenic illnesses in human
populations around the world (Ochoa et al., 2008).
Shiga toxin-producing E. coli/EHEC and EPEC strains encode
a number of virulence factors in a chromosomally located
pathogenicity island termed the locus for enterocyte effacement
(LEE; McDaniel et al., 1995). Intimate adhesion of STEC/EHEC
and EPEC to enterocytes is mediated in part by LEE-encoded
intimin gene (eae), resulting in the formation of an attaching and
effacing (A/E) lesion on the surface of the intestinal cells. In addi-
tion to virulence factors encoded in the LEE pathogenicity island,
EHEC and EPEC possess one or more of the chromosomally
encoded long polar fimbriae (lpf) loci. Together with intimin, Lpf
is the only other well-characterized colonization factor of EHEC
O157:H7 (Torres et al., 2002, 2004, 2007). Our group conducted
an extensive study involving A/E-producing bacterial collections
from Europe and South America and demonstrated a correlation
between lpf genes and different genetic variants of the intimin
genes in A/E-producing E. coli (AEEC; Torres et al., 2009). The
lpf genes are also widely distributed throughout pathogenic and
some commensal populations of E. coli and can be categorized
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into distinct allelic variants (Galli et al., 2010; Gomes et al., 2011).
Additionally, other groups have also reported the potential use of
intimin for diagnostics based on the correlation of intimin type
and lineage of STEC/EHEC and EPEC strains (Tarr and Whittam,
2002; Zhang et al., 2002; Jores et al., 2003). Due to the broad dis-
tribution of lpf and eae genes in AEEC and their association with
these pathogenic E. coli strains, the lpf and eae subtypes could be
used to genetically identify and distinguish diverse STEC/EHEC
and EPEC serogroups (Torres et al., 2009). From a clinical point of
view, the inclusion of primers for stx genes is critical, as the pro-
gression to HUS is strongly influenced by the presence of Shiga
toxin (Friedrich et al., 2002; Brooks et al., 2005; Hedican et al.,
2009). Further, the bfpA gene can be used as marker to detect typ-
ical (bfp+) and atypical (bfp−) EPEC strains (Nataro and Kaper,
1998).
Current proposed approaches for the specific detection of
EHEC strains in clinical samples or food matrices are focused on
thedetectionof genes present in a limitednumber of serotypes. For
example, the inclusion of the E. coli O157:H7 O-antigen marker
rfbEO157 limits the detection of strains to O157 serogroups (Bai
et al., 2010; Gordillo et al., 2011). Analysis of multiple O-group
genes improves the detection capabilities of an assay, but does not
remove the constraint of detecting only known serogroups (Madic
et al., 2011). Similar constraints are present when targeting the H7
fliC flagellar antigen (Madic et al., 2010; Gordillo et al., 2011)
or when employing O157 strain-specific methodologies (Ooka
et al., 2009). A recent study utilized genes encoding intimin and
Shiga toxin to detect EHEC and EPEC strains, yet the assay was
not designed to specifically detect O157 strains (Pavlovic et al.,
2010).
In developing countries, enteric pathogen identification is
frequently time consuming and incomplete, resulting in poten-
tial misdiagnoses or mistreatments. Therefore, a rapid, spe-
cific assay designed to identify EHEC/STEC and EPEC strains
in a public health setting would be advantageous to help
ensure that a timely and proper response is initiated. Fur-
thermore, assays like this one would accelerate the diagno-
sis and significantly reduce mortality in endemic areas. Spe-
cific identification of highly pathogenic EHEC would also
be critical in the event of food-borne illness outbreaks or
agroterrorism.
Therefore, our study addresses the aforementioned constraints
on the detection of these diarrheagenic E. coli (DEC) cate-
gories by using genes that do not encode serogroup-specific anti-
gens, yet can distinguish O157:H7 strains, as well as unknown
serogroups. We examined the hypothesis that re-emerging and
outbreak-associated E. coli strains can be rapidly, specifically,
and easily distinguished using multiplex PCR (mPCR) amplifica-
tion of specific biomarkers associated with each strain’s respec-
tive virulence genotype. The results of our mPCR assay indi-
cate that this approach can provide a rapid method for detec-
tion of pathogenic E. coli strains. We demonstrated that lpfA
subtypes could distinguish between EHEC and EPEC groups
and most importantly, inclusion of lpfA variants permitted
detection of EHEC O157:H7 in 100% of the cases, further
supporting the importance of lpfA in molecular diagnostics
approaches.
MATERIALS AND METHODS
STRAINS
Enterohemorrhagic E. coli O157:H7 strain EDL933, EPEC
O127:H6 strain E2348/69, E. coli K12 strain MG1655, E. coli HS,
Salmonella enterica serovar Typhimurium 2157, Shigella flexneri
M90T, adherent invasiveE. coli O83:H1NRG857c, enterotoxigenic
E. coli H10407, enteroaggregative E. coli O42, and 78 isolates from
the DEC Collection (Whittam et al., 1993) were grown in Luria–
Bertani (LB) broth at 37˚C with shaking. Genomic DNA (gDNA)
was extracted from the cells using the DNeasy Blood and Tissue
Kit (Qiagen, Valencia, CA, USA).
PCR
Single and mPCR reactions were carried out using REDTaq
ReadyMix PCR Reaction Mix and REDTaq DNA Polymerase
(Sigma, St. Louis, MO, USA) supplemented with the appropri-
ate primers and template DNA. Oligonucleotide primer sequences
wereused frompreviously publishedworkormanually designed to
obtain amplicons of sufficiently different sizes to be resolved in the
multiplex assay (Tables 1 and 2). Primer sets specifically designed
in this study utilized sequences for eae-α (FM180568), eae-β
(AF081186), eae-γ (AE005174), eae-δ (AJ875027), and lpfA1-1
(NC_011601). Single PCR reactions using REDTaq ReadyMix
(Sigma, St. Louis,MO,USA) and 0.8mM of each primer were per-
formed under the following conditions: 94˚C for 5min; 30 cycles
of 94˚C for 30 s, 42˚C for 45 s, 72˚C for 35 s; 72˚C for 10min; hold at
10˚C. Multiplex reactions using an additional 0.8 units of REDTaq
DNA polymerase (1.4 units total per reaction – supplementation
with extra polymerase permitted an increase in specificity and
band intensity) were performed under the following conditions
using the primer concentrations indicated in Table 1: 94˚C for
5min; 40 cycles of 94˚C for 30 s, 59˚C for 1min 30 s, 72˚C for 40 s;
72˚C for 10min; hold at 10˚C. Products were analyzed on 1.5%
agarose gels.
THRESHOLD OF MULTIPLEX PCR ASSAY DETECTION
The assay was performed by first re-suspending cells (EHEC
O157:H7 EDL933 or EPEC O127:H6 E2348/69) freshly streaked
onto LB agar to an estimated concentration of ∼4× 109 cells/ml
by monitoring the OD600. Ten-fold serial dilutions were made into
sterile distilled water, which was then used as template directly in
mPCR reactions.
ISOLATION AND MOLECULAR CHARACTERIZATION OF CLINICAL
STRAINS
One hundred fecal samples (43 HUS, 36 non-bloody diarrhea,
and 21 bloody diarrhea cases) submitted to the National Refer-
ence Laboratory (NRL) in Buenos Aires, Argentina were studied.
Fecal samples were plated either directly onto sorbitol Mac-
Conkey agar or after enrichment at 37˚C for 4 h in trypticase soy
broth with or without cefixime (50 ng/ml) and potassium tellu-
rite (25mg/ml). Confluent growth zones were first screened for
stx1, stx2, and rfbO157 genes by mPCR (Leotta et al., 2005). A
single PCR targeting the eae gene was performed (Karch et al.,
1993; Karch and Bielaszewska, 2001) as well as testing of the
eae variants (Ramachandran et al., 2003), if mPCR for the stx1,
stx2, and rfbO157 genes was negative. Isolates with stx1, stx2,
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Table 1 |Virulence-associated genes and primers used in this study.
Target Primer sequences Primer conc. in multiplex PCR (mM) Amplicon size (bp) Reference
stx2-F 50-ATCCTATTCCCGGGAGTTTACG-30 1 587 Cebula et al. (1995)
stx2-R 50-GCGTCATCGTATACACAGGAGC-30 1
eae-γ-F 50-CAGGTTGGGGTAACGGACTTTAC-30 1 472 This study
eae-γ-R 50-TTGCTTGCGTTTGAGACTTACCGTTG-30 1
lpfA1-1-F 50-GTGCTGGATTCACCACTATTCATCGC-30 0.2 389 This study
lpfA1-1-R 50-GCCTTGTCTGCACTGGCATTAACTTC-30 0.2
stx1-F 50-CAGTTAATGTGGTKGCGAAGG-30 1 348 Cebula et al. (1995)
stx1-R 50-CACCAGACAATGTAACCGCTG-30 1
bfpA-F 50-AATGGTGCTTGCGCTTGCTGC-30 0.2 326 Aranda et al. (2007)
bfpA-R 50-GCCGCTTTATCCAACCTGGTA-30 0.2
lpfA2-2-F 50-CTACAGGCGGCTGATGGAACA-30 0.2 297 Torres et al. (2009)
lpfA2-2-R 50-GCTAATACCAGCGGCAGCATCGT-30 0.2
lpfA1-3-F 50-GGTTGGTGACAAATCCCCG-30 0.2 244 Torres et al. (2009)
lpfA1-3-R 50-CGTCTGGCCTTTACTCAGA-30 0.2
eae-F 50-CTTTGACGGTAGTTCACTGGACTTC-30 0.2 166 This study
eae-R 50-GAAGACGTTATAGCCCAACATATTTTCAGG-30 0.2
Table 2 | Gene profiles for differentiation of E. coli pathotypes.
Pathotype (serotype) Gene targets in multiplex PCR assay
eae lpfA stx bfpA
EHEC (O157:H7) eae-γ lpfA1-3 and lpfA2-2 stx1 and/or stx2 NA
STEC various eae Various lpf stx1 and/or stx2 NA
LEE− – STEC NA lpfA1-2 and/or lpfA2-1 stx1 and/or stx2 NA
Typical EPEC (O127:H6) eae-α lpfA1-1 NA bfpA
Atypical EPEC eae-β lpfA1-2 and/or lpfA2-1 stx1 and/or stx2 NA
NA, not applicable.
and/or eae genes were identified by standard biochemical tests,
serotyped, and characterized by phenotypic and genotypic tech-
niques (Rivas et al., 2011). For comparison purposes, the same
DNA templates were screened by the mPCR developed in the
present study using Platinum Taq DNA Polymerase (Invitrogen,
Brazil). This study was carried out in strict accordance with the
Guidelines of the National Institutes of Health and the Ministry
of Health, Argentina. The protocol was approved by the Institu-
tional Review Board of the University of Texas Medical Branch
(IRB#11-081).
RESULTS
MULTIPLEX PCR ANALYSIS OF STRAINS FROM A DIARRHEAGENIC
E. COLI COLLECTION
The present work describes the development of an mPCR assay for
the rapid detection of specific categories of pathogenic E. coli. The
assay is based on the use of pathotype-specific genes for the detec-
tion of medically relevant E. coli strains, and is able to specifically
detect EHEC, typical and atypical EPEC, and STEC strains.
We demonstrated robust amplification of genes specific to
EHEC O157:H7 strain EDL933 (lpfA1-3, lpfA2-2, stx1, stx2, and
eae-γ) and EPEC O127:H6 strain E2348/69 (eae-α, lpfA1-1, and
bfpA) using an optimized mPCR protocol with purified gDNA.
Amplification of genes encoding virulence factors specific to
pathogenic E. coli (Table 2) was first tested in single PCR reactions.
One amplification product was observed in each case (data not
shown). During optimization of the multiplex reaction, the addi-
tion of REDTaq DNA polymerase to the polymerase already
present in the 1× solution of REDTaq ReadyMix permitted an
increase in the annealing temperature (thereby increasing speci-
ficity) and robustness of the assay. Modification of primer con-
centration, total number of cycles, and primer annealing time
were also optimized. To assess the efficacy of this assay on clin-
ical isolates, gDNA from strains in the DEC collection (Whittam
et al., 1993), representing a variety of serotypes from the EHEC
(clonal groups EHEC1 and EHEC2) and EPEC (clonal groups
EPEC1 and EPEC2),was screened using mPCR (Figure 1). Ampli-
con sizes from each DEC sample were compared to those in
the control strains to compose a genotype for each representa-
tive DEC group member. We determined that mPCR analysis
using gDNA from DEC isolates was successful in predicting the
correct pathotype in 75.6% (59/78) of the total number of iso-
lates; however the assay was able to predict the pathotype of all
EHEC1 (DECs 3, 4, and 5) and EPEC1 (DECs 1 and 2) and
distinguish between EHEC1 and EHEC2 (DECs 8, 9, and 10)
pathogroups.
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FIGURE 1 | Multiplex PCR screening of representatives from each diarrheagenic E. coli collection (DEC) group. (A) DEC 1–8; (B) DEC 9–15, M – 100bp
DNA markers (NEB). EHEC/EPEC, positive controls; (−), no template control.
FIGURE 2 | Determination of biological assay specificity. Multiplex PCR
assay was performed using gDNA from pathogenic and commensal enteric
bacteria. M, 100 bp DNA markers (NEB); EHEC, enterohemorrhagic E. coli ;
EPEC, enteropathogenic E. coli ; E. coli HS and E. coli K12, human intestinal
commensal and laboratory strains; S. flexneri, Shigella flexneri ; S.
typhimurium, Salmonella enterica serovar Typhimurium 2157; ETEC,
enterotoxigenic E. coli H10407; EAEC, enteroaggregative E. coli O42;
AIEC, adherent/invasive E. coli O83:H1; (−), no template control. The
position of the amplicons in the EHEC and EPEC strains are indicated on
the right of the figure.
ANALYTICAL SENSITIVITY OF MULTIPLEX PCR ASSAY
To assess the specificity of the assay, the multiplex reaction setup
was tested using gDNA from commensal E. coli strains and path-
ogenic enteric bacteria. Relatively low intensity amplicons slightly
larger than the size of the eae product were observed in three of
the seven strains tested (two E. coli strains [one commensal and
one laboratory isolate] and Shigella flexneri; Figure 2). With the
Salmonella strain used, we observed a product of approximately
300 bp, possibly due to amplification of an uncharacterized lpfA
variant in that strain. A smaller, faint amplicon was also observed
using the Salmonella strain; however, its size does not correspond
to any of the amplicons expected in our assay. Analysis of the com-
mensal E. coli HS revealed another faint, non-specific product not
corresponding to the size of a target amplicon (Figure 2).
ANALYTICAL SPECIFICITY OF MULTIPLEX PCR ASSAY
We then determined the in vitro threshold of detection with the
EHEC and EPEC prototype strains. Colonies from freshly streaked
LB agar plates were re-suspended in sterile distilled water to a con-
centration of ∼4× 109 cells/mL. A 5μl aliquot from each of the
10-fold serial dilutions were added to mPCR reactions to per-
mit testing of a 10-fold range of template concentrations from
1× 109 to 1× 103 cells/mL in a 20μl reaction. The threshold of
detection for EHEC and EPEC in vitro was determined to be
∼2× 104 CFU/reaction (corresponding to 1× 106 cells/ml in each
reaction), assessed by visibility of all six predicted amplicons for
EHEC and all three amplicons for EPEC (Figure 3).
EVALUATION OF MULTIPLEX PCR ASSAY AT NRL (ARGENTINA)
Next, we tested the feasibility to implement our mPCR in a clin-
ical setting, performing a trial study with samples received at the
National Reference Laboratory (NRL), Argentina, and compar-
ing the results to methods already optimized in that laboratory
(Table 3). The clinical sensitivity and specificity of the assay was
estimated to be 91% and 84%, respectively. Identification of at
least one gene (eae, one of the stx genes, or rfbO157 ) was the basis
for determining whether a given case was considered positive or
negative.
Further analysis of non-O157 and non-O145 isolates revealed
that although the mPCR assay typically identified eae-γ in these
isolates, RFLP–PCR intimin typing (Ramachandran et al., 2003) at
the NRL revealed eae-β or eae-θ in the non-O157 and non-O145
cases (data not shown). These findings likely represent a false pos-
itive indication of the presence of eae-γ, as strains that possess
eae-γ typically contain lpfA1-3 and lpfA2-2 as well, both of which
are absent in the eae-β and eae-θ strains.
Inonepositive case (Table 3, isolate 4), themPCRassaywaspos-
itive for both stx1 and stx2, while the stx-negative result at the NRL
was confirmed using RFLP–PCR (Tyler et al., 1991; Zhang et al.,
2002). In two other cases, the standardmethodology revealed eae+
strains, whereas the mPCR assay indicated that the strains lacked
intimin (Table 3, isolates 31 and 32). Interestingly, analysis of iso-
lates 30–34 revealed that the mPCR produced amplicons for both
lpfA1-3 and lpfA2-2only (Table 3). Despite indicating a positive
result for two of the markers for O157:H7 strains, that serotype
was not confirmed in those isolates (Table 3).
In the 11 cases where the NRL indicated negative results and
the mPCR assay indicated positive results (Table 3, isolates 90–96,
97, 100), nine of them were considered false positives for eae, as
they were further confirmed to be negative for eae subtypes by
Frontiers in Cellular and Infection Microbiology www.frontiersin.org February 2012 | Volume 2 | Article 8 | 4
Botkin et al. mPCR for pathogenic E. coli
FIGURE 3 | Determination of detection threshold. Serial dilutions of
re-suspended EHEC EDL933 or EPEC E2348/69 colonies were used
as template in the multiplex PCR reaction. M – 100bp DNA markers
(NEB). Number above each lane indicates the concentration (cells/ml)
of bacteria per reaction. Consistent detection of (A) all of six EHEC
EDL933-specific bands and (B) all three EPEC E2348/69-specific
bands was observed using 2×104 cells in a 20μl PCR reaction. ×,
lane was not loaded; (−), no template control. The position of the
amplicons in the EHEC and EPEC strains are indicated on the right of
each panel.
RFLP–PCR. Two strains identified by the described mPCR assay
as either stx1+ (Table 3, isolate 100) or stx2+ (Table 3, isolate 97)
were confirmed as stx-negative by RFLP–PCR.
While the assay can reliably detect EHEC, STEC, and typical or
atypical EPEC strains, the repertoire of pathotype detection can
be expanded by the inclusion of primers for lpfA1-2 and lpfA2-1.
The LEE− negative STEC typically possess one or both of these
lpfA subtypes (Galli et al., 2010; Gomes et al., 2011). Additionally,
detection of lpfA1-2 and/or lpfA2-1 permits the differentiation of
strains from the EHEC2 (DECs 8, 9, and 10) and EPEC2 (DECs 11
and 12) clonal groups (Figure 4, data not shown). The EHEC
and EPEC pathotypes were identified after examining a num-
ber of diarrheagenic strains by multilocus enzyme electrophoresis
and serotyping, and appear to represent distinct clonal lineages of
pathogenic E. coli (Whittam and McGraw, 1996; Reid et al., 2000).
The unique ability of the multiplex assay to specifically detect
EHEC and EPEC clonal groups is predominantly conferred by
lpfA subtype analyses (Figure 4). Using DEC collection isolates
(Whittam et al., 1993), clonal group EHEC1 (DECs 3, 4, and
5) were detected, in part, by the inclusion of primers amplifying
EHECO157:H7-specific lpfA subtypes 1-3 and 2-2. EPEC1 isolates
(DECs 1 and 2) and EPEC O127:H6 were specifically identified by
the amplification of lpfA1-1. The addition of lpfA subtyping was
advantageous since lpfA subtypes differ among EHEC and EPEC
clonal groups (Torres et al., 2009). As such, it permitted us to dif-
ferentiate the more common EHEC1 and EPEC1 clonal groups
from members of the EHEC2 and EPEC2 categories, respec-
tively. Further specificity was conveyed by the amplification of
pathotype-specific intimin subtypes: γ-intimin was used to detect
EHEC1 isolates and α-intimin was used to detect EPEC1 isolates.
DISCUSSION
A panel of eight genes was employed for the design of a sensitive
and specific mPCR assay to facilitate detection of three pathotypes
of E. coli that cause significant morbidity and mortality across the
world – EHEC, STEC, and EPEC. The assay was also designed to be
relatively low-cost, as compared to the financial burden of acquir-
ing instrumentation and consumables to perform real-time PCR
ormultiplex bead-based assays. A collection of DEC strains (Whit-
tam et al., 1993) was tested using the assay, and we demonstrated a
relatively high degree of agreement between the mPCR results and
strain information present in the DEC database. Evaluation of the
specificity revealed no significant cross-reactivity of the primers
with other E. coli pathotypes. The detection threshold of the assay
was determined to be comparable to other PCR-based methods
for detection of E. coli isolates (Aranda et al., 2007; Antikainen
et al., 2009; Vidová et al., 2011). Of particular significance is the
observation that defined combinations of lpfA subtypes permitted
differentiation of EHEC and EPEC clonal groups.
Both EHEC and EPEC are AEEC strains, possessing the LEE-
encoded gene products for development of the intestinal lesions
(McDaniel and Kaper, 1997). The presence of the LEE-encoded
adhesin intimin gene eae (Jerse and Kaper, 1991), is indicative
of these strains, and; therefore, a first primer set was designed to
amplify only eae-γ, previously demonstrated to be associated with
the EHEC1 clonal group (Adu-Bobie et al., 1998; Reid et al., 1999).
The second eae primer set was engineered to be more generic,
amplifying the remaining major eae subtypes α, β, and δ (Adu-
Bobie et al., 1998). Importantly, intimin α is associated with the
EPEC1 clonal group, while intimin β is indicative of members of
the EPEC2 clonal group (Adu-Bobie et al., 1998; Reid et al., 1999).
Thus, themultiplex assay has the potential to detect a large number
of AEEC strains.
In the multiplex strategy, the addition of primers for lpfA sub-
typing conferred the greatest increase in the ability of the assay to
differentiate members of the EHEC and EPEC clonal groups. Lpf
are elaborated appendages important for pathogenesis and adher-
ence to cultured cells (Torres et al., 2002, 2004), persistence in
animal models (Jordan et al., 2004; Torres et al., 2007), and tissue
tropism in the human intestine (Fitzhenry et al., 2006). In addi-
tion, the combination of lpfA and eae subtyping can specifically
detect EHEC O157:H7 (Torres et al., 2009), providing a distinct
time advantage over more conventional culture- or immunoassay-
based methodologies for the detection of O157:H7 strains.
Primer sets for both Shiga toxin 1 (stx1) and Shiga toxin 2
(stx2) were incorporated into the assay to facilitate identification
of STEC strains, because early detection is critical for determining
appropriate therapies for patients with suspected E. coli infec-
tions. Although there are a number of stx2 variants, we included
primers based on the E. coli O157:H7 stx2 sequence due to the link
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Table 3 | Comparison of results between molecular diagnostic assays at NRL and the current proposed mPCR methodology.
Results of assays1
Isolate no. (serotype)
Diagnosis2 PCR (NRL) mPCR (UTMB)
eae rfbO157 stx1 stx2 eae eae-γ stx1 stx2 lpfA1-3 lpfA2-2
NRL POSITIVE/mPCR POSITIVE
1 (ONT:motile) BD + − − − + + − − − −
2 (OR:motile) D + − − − + − − − − −
3 (O157:H7) BD + + − + + + − + + +
4 ND HUS + − − − + − + + − −
5 (O157:H7) HUS + + − + + + − + + +
6 (O157:H7) BD + + − + + + − + + +
7 (O145:NM) HUS + − − + + + − + − −
8 ND HUS + − + − + + + + − −
9 (O157:H7) BD + + − + + + − + + +
10 (O157:H7) HUS + + − + + + − + + +
11 (O157:H7) HUS + + − + + + − + + +
12 (O145:NM) D + − − + + + − + − −
13 (O157:H7) HUS + + − + + + − + + +
14 (ONT:motile) HUS + − − − + + − − − −
15 (O26:NM) BD + − − − + − − − − −
16 (O26:H11) D + − − + + + − + − −
17 (O145:NM) HUS + − − + + + − + − −
18 (O145:NM) HUS3 + − − + + + − + − −
19 (O145:NM) BD + − − + + + − + − −
20 ND D + − − − + − − − − −
21 ND D + − − − + + − − − −
22 (O145:NM) D + − − + + + − + − −
23 (O145:NM) D + − − + + + − + − −
24 (O157:H7) HUS + + − + + + − + + +
25 (O157:H7) BD + + − + + + − + + +
26 (ONT:H46) BD + − − + + − − + − −
27 (O145:HNM) HUS + − − + + + − + − −
28 (O157:HNT) HUS + + − − + − − − − −
29 (O157:H7) HUS + + − + + + − + + +
NRL POSITIVE/mPCR NEGATIVE
30 (O157:HNT) BD − + − − − − − − + +
31 ND D + − − − − − − − + +
32 ONT:HNT BD + − − − − − − − + +
NRL NEGATIVE/mPCR NEGATIVE
33 ND D − − − − − − − − + +
34 ND HUS − − − − − − − − + +
35−89 ND 23 D − − − − − − − − − −
9 BD − − − − − − − − − −
23 HUS − − − − − − − − − −
NRL NEGATIVE/mPCR POSITIVE
90 ND D − − − − + − − − − −
91 ND HUS − − − − + − − − − −
92 ND HUS − − − − + − − − − −
93 ND HUS − − − − + − − − − −
94 ND BD − − − − + − − − − −
95 ND HUS − − − − + − − − − −
96 ND HUS − − − − + − − − − −
97 ND BD − − − − − − − + − −
(Continued)
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Table 3 | Continued
Results of assays1 Diagnosis2 PCR (NRL) mPCR (UTMB)
Isolate no. (serotype) eae rfbO157 stx1 stx2 eae eae-γ stx1 stx2 lpfA1-3 lpfA2-2
98 ND D − − − − + − − − − −
99 ND D − − − − + − − − − −
100 ND D − − − − − − + − − −
1Positivity is defined as genetic evidence for an O157, attaching/effacing-, or Shiga toxin-producing E. coli isolate.
2D, diarrhea; BD, blood diarrhea; HUS, hemolytic uremic syndrome.
3Patient died.
ND serotype not determined (unable to isolate a strain).
FIGURE 4 | Phylogeny and lpfA subtype of isolates in diarrheagenic
E. coli (DEC) collection. DEC clone numbers (Reid et al., 1999),
corresponding predominant serotype of the given group,
pathotype/intimin subtype, and information regarding lpfA subtype(s)
for each group are indicated (Adapted fromTorres, 1999 Ph.D.
Dissertation). The lpfA1-2 and lpfA2-1 were previously identified in
EHEC2 and EPEC2 isolates (Torres et al., 2009). ND, not determined
(none of the three lpfA subtypes included in the multiplex PCR were
detected, and lpfA subtypes were not studied further during the
multiplex PCR project).
between the development of HUS and the presence of stx2, partic-
ularly inO157:H7 strains (Friedrich et al., 2002; Brooks et al., 2005;
Hedican et al., 2009). Conversely, the assay is capable of detecting
non-O157 STEC,a groupof under-diagnosed emerging pathogens
(Coombes et al., 2011), and emerging LEE-negative STEC strains
(Newton et al., 2009; Galli et al., 2010).
To further expand the detection capabilities, primers to amplify
the bundle-forming pili subunit bfpA were incorporated into the
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assay. Because the bundle-forming pilus is a central virulence fac-
tor of EPEC strains, playing a putative role in initial attachment to
enterocytes (Cleary et al.,2004) andmicrocolony formation (Hicks
et al., 1998), the bfpA gene can be used as a marker for identifi-
cation of typical EPEC (Nataro and Kaper, 1998) in conjunction
with eae (Giron et al., 1993).
Our mPCR results with DEC collection isolates suggest that
this approach will prove useful for rapid identification of these
pathogenic E. coli strains. The incidence of non-specific ampli-
fication was low, and in many cases, the bands were faint
compared to the intensities of the primer-specific products
and outside the size range of the target amplicons (data not
shown). The presence of non-specific amplicons is not antic-
ipated to result in the misidentification of strains as DEC,
and is not uncommon in mPCR approaches (Antikainen et al.,
2009).
The diagnostic sensitivity and specificity was calculated to be
91% and 84%, respectively, when comparing to the “standard”
methodology used by the NRL (Argentina) for routine detec-
tion of highly virulent STEC strains and our mPCR assay. These
data strongly suggest that the mPCR approach described here is
a relatively low-cost and feasible screening methodology for clin-
ical fecal samples within 24 h of obtaining a specimen. Because
Argentina possesses the highest incidence of post-enteric HUS in
infants and children in the world, and O157:H7 and O145:NM
are the most prevalent serotypes (Rivas et al., 2010, 2011), this
new mPCR approach permits rapid identification of STEC strains
involved in the majority of the cases (>70%) received at the NRL.
Further, this method can also be used in areas where other STEC
or EPEC strains are prevalent.
Assay specificity was determined by screening additional E. coli
pathotypes, commensal E. coli, and a limited number of non-E.
coli intestinal pathogens. This analysis revealed that the assay is
highly specific; none of the unexpected amplification products
correspond to the size of a predicted amplicon (Figure 2). Minor
cross-reactivity of the broad-range intimin primers with a putative
intimin gene in E. coli K12 (eaeH ) and E. coli HS (EcHS_A0351)
may account for the observation of a band migrating at approxi-
mately the same size as the specific intimin target observed using
EHEC or EPEC. However, S. flexneri does not appear to possess a
putative intimin sequence.
The threshold detectionof ourmultiplex approachwas assessed
and the template concentrations at which all expected ampli-
cons were clearly visible on the gel was set as the limit for
detection of that pathotype. EHEC and EPEC were detectable
at or above 2 × 104 CFU per reaction (Figure 3). Compared
to other mPCR methodologies (Aranda et al., 2007; Antikainen
et al., 2009; Vidová et al., 2011), the sensitivities determined
here are slightly higher, perhaps owing to the selection of DNA
polymerase. The REDTaq Ready Mix was chosen based on the
premixed nature of the components, thereby reducing pipetting
errors and increasing reproducibility, and its relatively low-cost, a
factor critical for adoption of this assay in developing countries.
The balance between assay cost and sensitivity can be adjusted
based on the financial resources of the testing facility, suggesting
that the purchase of more costly polymerases could increase assay
sensitivity.
The observation that lpfA and eae subtypes are related to spe-
cific EHEC and EPEC clonal groups provides evidence of the
lineage of pathogenic E. coli, but also permitted us to design an
assay exploiting these phylogenetic relationships (Figure 4). In its
current form, the mPCR assay can reliably distinguish strains in
the EHEC1 and EPEC1 clonal groups, atypical EPEC, and differ-
entiate O157 and non-O157 STEC strains. Interestingly, isolates
from the EPEC2 group (DEC 11 and DEC 12) were negative for
bfpA. This result likely reflects the specificity of the bfpA primer
set for the bfpAα1 allele present in the O127:H6 prototype EPEC
strain (Blank et al., 2000). Therefore, strategies for detection of
EPEC2 strains should also include primers to amplify the β4 (DEC
11) and α2 (DEC 12) bfpA alleles (Blank et al., 2000). While not
included in the samemPCRassay,detection of additional lpfA sub-
types would permit identification of EHEC2 and EPEC2 strains, as
well as afford detection of LEE-negative STEC (eae−, stx+, lpfA1-
2+, and/or lpfA2-1+) and atypical EPEC (eae+, bfpA−, lpfA1-2+,
and/or lpfA2-1+). Recent data also supports this notion, as Gomes
et al. (2011) demonstrated that of the lpfA+ atypical EPEC strains
tested, lpfA1-2 and lpfA2-1 were frequently present together in a
given strain. Finally, the lpfA1-1 variant was used to identify typical
EPEC strains; however, this allele was present in only 35% (16/46)
of the isolates tested. Currently, we are exploring the possibility to
incorporate alternative lpfA1 alleles identified in our initial screen
(Torres et al., 2009) to increase the specificity of our assay.
In summary, we presented data supporting a mPCR approach
that, with only eight virulence-associated genes, has the poten-
tial detect a wide range of pathogenic E. coli strains. The assay was
testedwith a collectionof clinical isolates, resulting in a highdegree
of agreement between known strain information and the results of
the mPCR. The specificity and sensitivity of the assay are such that
diagnostic facilities in developing countries can easily incorpo-
rate this methodology into their workflow. The mPCR approach
described here has potential for improving both diagnostics and
epidemiological studies involving DEC.
ACKNOWLEDGMENTS
The work in the AGT laboratory was supported by NIH/NIAID
grant 5-R01-AI079154. Douglas J. Botkin was supported by an
NIH/NIAIDT32Postdoctoral TrainingGrant inEmerging andRe-
emerging Infectious Diseases, 5-T32-AI007536-12. The authors
would like to thank members of Servicio Fisiopatogenia and the
Torres lab for their support and critical review of this project. The
authors also thank Dr. Heidi Spratt for help with statistical analy-
ses. The contents are solely the responsibility of the authors and do
not necessarily represent the official views of the RCE Programs
Office, NIAID, or NIH.
REFERENCES
Adu-Bobie, J., Frankel, G., Bain, C.,
Goncalves, A. G., Trabulsi, L. R.,
Douce, G., Knutton, S., and Dougan,
G. (1998). Detection of intimins
alpha, beta, gamma, and delta,
four intimin derivatives expressed
by attaching and effacing micro-
bial pathogens. J. Clin. Microbiol. 36,
662–668.
Antikainen, J., Tarkka, E., Haukka,
K., Siitonen, A., Vaara, M., and
Kirveskari, J. (2009). New 16-plex
PCR method for rapid detection
of diarrheagenic Escherichia coli
directly from stool samples. Eur.
J. Clin. Microbiol. Infect. Dis. 28,
899–908.
Aranda, K. R., Fabbricotti, S. H.,
Fagundes-Neto, U., and Scaletsky,
Frontiers in Cellular and Infection Microbiology www.frontiersin.org February 2012 | Volume 2 | Article 8 | 8
Botkin et al. mPCR for pathogenic E. coli
I. C. (2007). Single multiplex
assay to identify simultaneously
enteropathogenic, enteroaggrega-
tive, enterotoxigenic, enteroinvasive
and Shiga toxin-producing
Escherichia coli strains in Brazilian
children. FEMS Microbiol. Lett. 267,
145–150.
Bai, J., Shi, X., and Nagaraja, T. G.
(2010). A multiplex PCR proce-
dure for the detection of six major
virulence genes in Escherichia coli
O157:H7. J. Microbiol. Methods 82,
85–89.
Blank, T. E., Zhong, H., Bell, A.
L., Whittam, T. S., and Donnen-
berg, M. S. (2000). Molecular vari-
ation among type IV pilin (bfpA)
genes from diverse enteropatho-
genic Escherichia coli strains. Infect.
Immun. 68, 7028–7038.
Brooks, J. T., Sowers, E. G., Wells, J.
G., Greene, K. D., Griffin, P. M.,
Hoekstra, R. M., and Strockbine, N.
A. (2005). Non-O157 Shiga toxin-
producing Escherichia coli infections
in the United States, 1983–2002. J.
Infect. Dis. 192, 1422–1429.
Cebula, T. A., Payne, W. L., and
Feng, P. (1995). Simultaneous iden-
tification of strains of Escherichia
coli serotype O157:H7 and their
Shiga-like toxin type by mis-
match amplificationmutation assay-
multiplex PCR. J. Clin.Microbiol. 33,
248–250.
Cleary, J., Lai, L. C., Shaw, R. K.,
Straatman-Iwanowska, A., Donnen-
berg, M. S., Frankel, G., and Knut-
ton, S. (2004). Enteropathogenic
Escherichia coli (EPEC) adhesion
to intestinal epithelial cells: role of
bundle-forming pili (BFP), EspA fil-
aments and intimin. Microbiology
150, 527–538.
Coombes, B. K., Gilmour, M. W.,
and Goodman, C. D. (2011).
The evolution of virulence in
non-O157 Shiga toxin-producing
Escherichia coli. Front. Microbiol.
2:90. doi:10.3389/fmicb.2011.00090
Fitzhenry, R., Dahan, S., Torres, A. G.,
Chong, Y., Heuschkel, R., Murch,
S. H., Thomson, M., Kaper, J.
B., Frankel, G., and Phillips, A.
D. (2006). Long polar fimbriae
and tissue tropism in Escherichia
coli O157:H7. Microbes Infect. 8,
1741–1749.
Friedrich, A. W., Bielaszewska, M.,
Zhang, W. L., Pulz, M., Kuczius,
T., Ammon, A., and Karch, H.
(2002). Escherichia coli harboring
Shiga toxin 2 gene variants: fre-
quency and association with clinical
symptoms. J. Infect. Dis. 185, 74–84.
Galli, L., Torres, A. G., and Rivas,
M. (2010). Identification of the
long polar fimbriae gene vari-
ants in the locus of enterocyte
effacement-negative Shiga toxin-
producing Escherichia coli strains
isolated from humans and cattle
in Argentina. FEMS Microbiol. Lett.
308, 123–129.
Giron, J. A., Donnenberg, M. S., Mar-
tin, W. C., Jarvis, K. G., and
Kaper, J. B. (1993). Distribution of
the bundle-forming pilus structural
gene (bfpA) among enteropatho-
genic Escherichia coli. J. Infect. Dis.
168, 1037–1041.
Gomes, T. A., Hernandes, R. T., Torres,
A. G., Salvador, F. A., Guth, B. E. C.,
Vaz, T. M., Irino, K., Silva, R. M.,
and Vieira, M. A. (2011). Adhesin-
encoding genes from Shiga toxin-
producing Escherichia coli are more
prevalent in atypical than in typi-
cal enteropathogenic E. coli. J. Clin.
Microbiol. 49, 3334–3337.
Gordillo, R., Cordoba, J. J., Andrade,
M. J., Luque, M. I., and Rodriguez,
M. (2011). Development of PCR
assays for detection of Escherichia
coli O157:H7 inmeat products.Meat
Sci. 88, 767–773.
Hedican, E. B., Medus, C., Besser, J.
M., Juni, B. A., Koziol, B., Tay-
lor, C., and Smith, K. E. (2009).
Characteristics of O157 versus
non-O157 Shiga toxin-producing
Escherichia coli infections in Min-
nesota, 2000–2006. Clin. Infect. Dis.
49, 358–364.
Hicks, S., Frankel, G., Kaper, J. B.,
Dougan, G., and Phillips, A. D.
(1998). Role of intimin and bundle-
forming pili in enteropathogenic
Escherichia coli adhesion to pedi-
atric intestinal tissue in vitro. Infect.
Immun. 66, 1570–1578.
Jerse, A. E., and Kaper, J. B. (1991).
The eae gene of enteropatho-
genic Escherichia coli encodes a 94-
kilodalton membrane protein, the
expression of which is influenced by
the EAF plasmid. Infect. Immun. 59,
4302–4309.
Jordan, D. M., Cornick, N., Torres, A.
G.,Dean-Nystrom,E. A., Kaper, J. B.,
and Moon,H.W. (2004). Long polar
fimbriae contribute to colonization
by Escherichia coli O157:H7 in vivo.
Infect. Immun. 72, 6168–6171.
Jores, J.,Zehmke,K.,Eichberg, J.,Rumer,
L. and Wieler, L. H. (2003). Descrip-
tion of a novel intimin variant
(type zeta) in the bovine O84:NM
verotoxin-producing Escherichia coli
strain 537/89 and the diagnostic
value of intimin typing. Exp. Biol.
Med. (Maywood) 228, 370–376.
Karch,H., Bohm,H., Schmidt,H., Gun-
zer, F., Aleksic, S., and Heesemann,
J. (1993). Clonal structure and
pathogenicity of Shiga-like toxin-
producing, sorbitol-fermenting
Escherichia coli O157:H7. J. Clin.
Microbiol. 31, 1200–1205.
Karch, H., and Bielaszewska, M.
(2001). Sorbitol-fermenting Shiga
toxin-producing Escherichia coli
O157:H(−) strains: epidemiology,
phenotypic and molecular char-
acteristics, and microbiological
diagnosis. J. Clin. Microbiol. 39,
2043–2049.
Leotta, G. A., Chinen, I., Epszteyn,
S., Miliwebsky, E., Melamed, I. C.,
Motter, M., Ferrer, M., Marey, E.,
and Rivas, M. (2005). Validation
of a multiplex PCR for detection
of Shiga toxin-producingEscherichia
coli. Rev. Argent. Microbiol. 37, 1–10.
Madic, J., Peytavin de Garam, C.,
Vingadassalon, N., Oswald, E., Fach,
P., Jamet, E., and Auvray, F. (2010).
Simplex and multiplex real-time
PCR assays for the detection of
flagellar (H-antigen) fliC alleles
and intimin (eae) variants asso-
ciated with enterohaemorrhagic
Escherichia coli (EHEC) serotypes
O26:H11, O103:H2, O111:H8,
O145:H28 and O157:H7. J. Appl.
Microbiol. 109, 1696–1705.
Madic, J., Vingadassalon, N., de Garam,
C. P., Marault, M., Scheutz, F.,
Brugere, H., Jamet, E., and Auvray,
F. (2011). Detection of Shiga
toxin-producing Escherichia coli
serotypes O26:H11, O103:H2,
O111:H8, O145:H28, and O157:H7
in raw-milk cheeses by using multi-
plex real-time PCR. Appl. Environ.
Microbiol. 77, 2035–2041.
McDaniel, T. K., Jarvis, K. G., Don-
nenberg, M. S., and Kaper, J. B.
(1995). A genetic locus of entero-
cyte effacement conserved among
diverse enterobacterial pathogens.
Proc. Natl. Acad. Sci. U.S.A. 92,
1664–1668.
McDaniel, T. K., and Kaper, J. B. (1997).
A cloned pathogenicity island from
enteropathogenic Escherichia coli
confers the attaching and effacing
phenotype on E. coli K-12. Mol.
Microbiol. 23, 399–407.
Nataro, J. P., and Kaper, J. B. (1998).
Diarrheagenic Escherichia coli. Clin.
Microbiol. Rev. 11, 142–201.
Newton, H. J., Sloan, J., Bulach, D.
M., Seemann, T., Allison, C. C.,
Tauschek, M., Robins-Browne, R.
M., Paton, J. C., Whittam, T. S.,
Paton, A. W., and Hartland, E.
L. (2009). Shiga toxin-producing
Escherichia coli strains negative
for locus of enterocyte effacement.
Emerging. Infect. Dis. 15, 372–380.
Ochoa, T. J., Barletta, F., Contreras,
C. and Mercado, E. (2008). New
insights into the epidemiology of
enteropathogenic Escherichia coli
infection. Trans. R. Soc. Trop. Med.
Hyg. 102, 852–856.
Ooka, T., Terajima, J., Kusumoto, M.,
Iguchi, A., Kurokawa, K., Ogura,
Y., Asadulghani, M., Nakayama, K.,
Murase, K., Ohnishi, M., Iyoda,
S., Watanabe, H., and Hayashi, T.
(2009). Development of a multiplex
PCR-based rapid typing method for
enterohemorrhagic Escherichia coli
O157 strains. J. Clin. Microbiol. 47,
2888–2894.
Orskov, F., Whittam, T. S., Cravioto, A.,
and Orskov, I. (1990). Clonal rela-
tionships among classic enteropath-
ogenic Escherichia coli (EPEC)
belonging to different O groups. J.
Infect. Dis. 162, 76–81.
Pavlovic, M., Huber, I., Skala, H.,
Konrad, R., Schmidt, H., Sing, A.,
and Busch, U. (2010). Develop-
ment of a multiplex real-time poly-
merase chain reaction for simultane-
ous detection of enterohemorrhagic
Escherichia coli and enteropatho-
genic Escherichia coli strains. Food-
borne Pathog. Dis. 7, 801–808.
Ramachandran,V., Brett, K., Hornitzky,
M. A., Dowton, M., Bettelheim, K.
A.,Walker,M. J., and Djordjevic, S. P.
(2003). Distribution of intimin sub-
types among Escherichia coli isolates
from ruminant and human sources.
J. Clin. Microbiol. 41, 5022–5032.
Reid, S. D., Betting, D. J., and Whittam,
T. S. (1999).Molecular detection and
identification of intimin alleles in
pathogenic Escherichia coli by mul-
tiplex PCR. J. Clin. Microbiol. 37,
2719–2722.
Reid, S. D., Herbelin, C. J., Bumbaugh,
A. C., Selander, R. K., and Whittam,
T. S. (2000). Parallel evolution of vir-
ulence in pathogenicEscherichia coli.
Nature 406, 64–67.
Rivas, M., Chinen, I., Miliwebsky,
E., Galli, L., Repetto, H. A., and
Masana, M. (2011). “Epidemiol-
ogy of Argentinean Shiga toxin-
producing Escherichia coli,” in Popu-
lation Genetics of Bacteria: A Tribute
to Thomas S.Whittam, eds S. T.Walk
and P. C. H. Feng (Washington, DC:
ASM Press), 109–132.
Rivas, M., Padola, N. L., Lucchesi, P.
M. A., and Massana, M. (2010).
“Diarrheagenic Escherichia coli in
Argentina,” in Pathogenic Escherichia
coli in Latin America, ed. A. G. Tor-
res (Oak Park, IL: Bentham Science
Publishers Ltd.), 142–161.
Tarr, C. L., and Whittam, T. S. (2002).
Molecular evolution of the intimin
gene O111 clones of pathogenic
Escherichia coli. J. Bacteriol. 184,
479–487.
Frontiers in Cellular and Infection Microbiology www.frontiersin.org February 2012 | Volume 2 | Article 8 | 9
Botkin et al. mPCR for pathogenic E. coli
Torres, A. G. (1999). Characterization
of the Heme Transport System in
Escherichia coli O157:H7, and Impor-
tance of Iron Uptake Systems in Vir-
ulence. University of Texas at Austin.
PhD Dissertation.
Torres, A. G., Blanco, M., Valenzuela,
P., Slater, T. M., Patel, S. D., Dahbi,
G., Lopez, C., Barriga, X. F., Blanco,
J. E., Gomes, T. A., Vidal, R., and
Blanco, J. (2009). Genes related
to long polar fimbriae of path-
ogenic Escherichia coli strains as
reliable markers to identify viru-
lent isolates. J. Clin. Microbiol. 47,
2442–2451.
Torres, A. G., Giron, J. A., Perna, N. T.,
Burland, V., Blattner, F. R., Avelino-
Flores, F., and Kaper, J. B. (2002).
Identification and characterization
of lpfABCC0DE, a fimbrial operon
of enterohemorrhagic Escherichia
coli O157:H7. Infect. Immun. 70,
5416–5427.
Torres, A. G., Kanack, K. J., Tutt, C. B.,
Popov, V., and Kaper, J. B. (2004).
Characterization of the second long
polar (LP) fimbriae of Escherichia
coli O157:H7 and distribution of LP
fimbriae in other pathogenic E. coli
strains. FEMS Microbiol. Lett. 238,
333–344.
Torres, A. G., Milflores-Flores, L.,
Garcia-Gallegos, J. G., Patel, S.
D., Best, A., La Ragione, R. M.,
Martinez-Laguna,Y. andWoodward,
M. J. (2007). Environmental regula-
tion and colonization attributes of
the long polar fimbriae (LPF) of
Escherichia coli O157:H7. Int. J.Med.
Microbiol. 297, 177–185.
Tyler, S. D., Johnson, W. M., Lior,
H., Wang, G., and Rozee, K. R.
(1991). Identification of verotoxin
type 2 variant B subunit genes
in Escherichia coli by the poly-
merase chain reaction and restric-
tion fragment length polymorphism
analysis. J. Clin. Microbiol. 29,
1339–1343.
Vidová, B., Tóthová, E., Blahut, L.,
Horváthová, V., and Godány,
A. (2011). Multiplex PCR for
detection of Escherichia coli
O157:H7 in foods. Biologia 66,
401–405.
Whittam, T. S., and McGraw, E. A.
(1996). Clonal analysis of EPEC
serogroups. Rev. Microbiol. 27,
7–16.
Whittam, T. S., Wolfe, M. L.,
Wachsmuth, I. K., Orskov, F.,
Orskov, I., and Wilson, R. A.
(1993). Clonal relationships among
Escherichia coli strains that cause
hemorrhagic colitis and infan-
tile diarrhea. Infect. Immun. 61,
1619–1629.
Zhang, W. L., Köhler, B., Oswald, E.,
Beutin, L., Karch, H., Morabito,
S., Caprioli, A., Suerbaum, S., and
Schmidt, H. (2002). Genetic diver-
sity of intimin genes of attaching
and effacing Escherichia coli strains.
J. Clin. Microbiol. 40, 4486–4492.
Conflict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or financial relationships that
could be construed as a potential con-
flict of interest.
Received: 14December 2011; paper pend-
ing published: 16 January 2012; accepted:
28 January 2012; published online: 1
February 2012.
Citation: Botkin DJ, Galli L, Sankara-
pani V, Soler M, Rivas M and Torres
AG (2012) Development of a multiplex
PCR assay for detection of Shiga toxin-
producing Escherichia coli, enterohem-
orrhagic E. coli, and enteropathogenic
E. coli strains. Front. Cell. Inf. Microbio.
2:8. doi: 10.3389/fcimb.2012.00008
Copyright © 2012 Botkin, Galli,
Sankarapani, Soler , Rivas and Torres.
This is an open-access article distributed
under the terms of the Creative Commons
Attribution Non Commercial License,
which permits non-commercial use,
distribution, and reproduction in other
forums, provided the original authors
and source are credited.
Frontiers in Cellular and Infection Microbiology www.frontiersin.org February 2012 | Volume 2 | Article 8 | 10
4
